Biohaven BHVN
NYSE BHVN
$15.69 -0.17 (-1.07%)
As of: Sep 4, 2026 · 3:59 PM EDT

Biohaven (BHVN) Total Liabilities (2021 - 2026)

Biohaven (BHVN) posted Total Liabilities of $336.9 million for Q1 2026, down 15.64% sequentially from $399.4 million in Q4 2025, and up 68.92% YoY from $199.5 million in Q1 2025.

Analysis

Biohaven (BHVN) Total Liabilities (2021 - 2026) Analysis & Trends

Biohaven has reported Total Liabilities for 6 years, with the latest figure at $336.9 million in Q1 2026.

  • Quarterly Total Liabilities rose 68.92% year-over-year to $336.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $336.9 million (up 68.92% YoY) and the FY2025 annual result came in at $399.4 million, up 108.36% from the prior year.
  • Total Liabilities fell to $336.9 million in Q1 2026 per BHVN's latest filing, from $399.4 million in the prior quarter.
  • Over five years, Total Liabilities peaked at $426.3 million in Q3 2025 and troughed at $35.4 million in Q3 2022.
  • A 5-year average of $205.5 million and a median of $191.7 million in 2024 frame the typical range for Total Liabilities.
  • The widest YoY moves for Total Liabilities: up 161.73% in 2023, down 30.71% in 2023.
  • Over 5 years, Total Liabilities stood at $123.0 million in 2022, then sank by 30.71% to $85.2 million in 2023, then soared by 124.87% to $191.7 million in 2024, then jumped by 108.36% to $399.4 million in 2025, then fell by 15.64% to $336.9 million in 2026.
  • According to Business Quant data, Total Liabilities over the past three periods registered $336.9 million, $399.4 million, and $426.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 7.18 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 10.02 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.62 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 4.20 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 1.72 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 4.00 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 4.20 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 10.03 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 1.35 Bn
10 Biohaven 2.37 Bn 2.10 Bn - 358.52 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 358.52 Mn
Mar 31, 2026 336.91 Mn
Dec 31, 2025 399.38 Mn
Sep 30, 2025 426.28 Mn
Jun 30, 2025 415.83 Mn
Mar 31, 2025 199.45 Mn
Dec 31, 2024 191.67 Mn
Sep 30, 2024 194.52 Mn
Jun 30, 2024 198.90 Mn
Mar 31, 2024 117.09 Mn
Dec 31, 2023 85.24 Mn
Sep 30, 2023 92.73 Mn
Jun 30, 2023 119.48 Mn
Mar 31, 2023 146.26 Mn
Dec 31, 2022 123.01 Mn
Sep 30, 2022 35.43 Mn
Jun 30, 2022 -25.00 Mn
Mar 31, 2022 -46.10 Mn
Dec 31, 2021 47.37 Mn
Sep 30, 2021 -321.51 Mn